Correlation Between Thrivent Limited and Biotechnology Ultrasector

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Thrivent Limited and Biotechnology Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Thrivent Limited and Biotechnology Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Thrivent Limited Maturity and Biotechnology Ultrasector Profund, you can compare the effects of market volatilities on Thrivent Limited and Biotechnology Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Thrivent Limited with a short position of Biotechnology Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Thrivent Limited and Biotechnology Ultrasector.

Diversification Opportunities for Thrivent Limited and Biotechnology Ultrasector

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Thrivent and Biotechnology is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Thrivent Limited Maturity and Biotechnology Ultrasector Prof in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Ultrasector and Thrivent Limited is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Thrivent Limited Maturity are associated (or correlated) with Biotechnology Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Ultrasector has no effect on the direction of Thrivent Limited i.e., Thrivent Limited and Biotechnology Ultrasector go up and down completely randomly.

Pair Corralation between Thrivent Limited and Biotechnology Ultrasector

Assuming the 90 days horizon Thrivent Limited is expected to generate 10.51 times less return on investment than Biotechnology Ultrasector. But when comparing it to its historical volatility, Thrivent Limited Maturity is 15.43 times less risky than Biotechnology Ultrasector. It trades about 0.24 of its potential returns per unit of risk. Biotechnology Ultrasector Profund is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  3,642  in Biotechnology Ultrasector Profund on May 27, 2025 and sell it today you would earn a total of  768.00  from holding Biotechnology Ultrasector Profund or generate 21.09% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Thrivent Limited Maturity  vs.  Biotechnology Ultrasector Prof

 Performance 
       Timeline  
Thrivent Limited Maturity 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Thrivent Limited Maturity are ranked lower than 19 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Thrivent Limited is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Biotechnology Ultrasector 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Biotechnology Ultrasector Profund are ranked lower than 13 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Biotechnology Ultrasector showed solid returns over the last few months and may actually be approaching a breakup point.

Thrivent Limited and Biotechnology Ultrasector Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Thrivent Limited and Biotechnology Ultrasector

The main advantage of trading using opposite Thrivent Limited and Biotechnology Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Thrivent Limited position performs unexpectedly, Biotechnology Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Ultrasector will offset losses from the drop in Biotechnology Ultrasector's long position.
The idea behind Thrivent Limited Maturity and Biotechnology Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Stocks Directory
Find actively traded stocks across global markets